AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2013
Aug 27, 2013
34519_dirs_2013-08-27_84a7adfe-755f-44c7-bd11-21a759d1d661.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2013-08-23
Reporting Person: ROTHSCHILD JONATHAN E (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-08-23 | Common Stock, par value $0.10 per share | P | 500 | $3.91 | Acquired | 464280 | Direct |
| 2013-08-23 | Common Stock, par value $0.10 per share | P | 500 | $4.01 | Acquired | 464780 | Direct |
| 2013-08-23 | Common Stock, par value $0.10 per share | P | 500 | $4.01 | Acquired | 465280 | Direct |
Footnotes
F1: This figure includes 214,655 shares of common stock held by Arterio Inc., a corporation owned solely by Mr. Rothschild.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23